Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.03 USD | -1.21% |
|
+0.78% | +26.65% |
Jun. 04 | Oppenheimer Raises Price Target on Crinetics Pharmaceuticals to $74 From $55, Maintains Outperform Rating | MT |
Jun. 03 | Transcript : Crinetics Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.65% | 3.59B | |
+37.15% | 51.12B | |
-6.66% | 39.4B | |
+37.72% | 38.48B | |
+12.84% | 26.36B | |
-12.11% | 26.22B | |
+17.57% | 20.96B | |
+43.46% | 14.02B | |
+32.01% | 12.49B | |
-2.68% | 11.61B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- JMP Securities Adjusts Crinetics Pharmaceuticals Price Target to $43 From $41, Maintains Market Outperform Rating